Skip to main content
. Author manuscript; available in PMC: 2012 May 1.
Published in final edited form as: Surgery. 2011 May;149(5):689–698. doi: 10.1016/j.surg.2011.02.007

Figure 3.

Figure 3

NIR fluorescent probe LS 301 and tumor imaging (A) Structural illustration of LS 301. (B) Comparison of NIR fluorescence and bioluminescence images at 24 hours post-injection of LS 301. NIR fluorescence corresponds well with the bioluminscence in the tumor regions. NIR fluorescence and white-light images were acquired with the goggle device. Fluorescence was psedocolored in red in the fluorescence-white light merge image. Bioluminescence image and radiograph were captured with Carestream In-Vivo Multispectral FX PRO imaging system.